Is Aviva Plc (ADR) (AV) an Exciting Emerging-Market Play?

Page 1 of 2

LONDON — While crippling austerity in Europe has put the brakes on growth rates in Europe, a backdrop of accommodative central-bank action, elevated commodity prices, and rising personal-affluence levels has created an exceptional investing opportunity in developing countries.

The divergence between traditional and emerging markets is borne out by the latest International Monetary Fund projections, which put U.S. growth at 1.9% in 2013, while eurozone GDP is set to dip 0.3%. Conversely, emerging markets are anticipated to expand 5.3% this year.

Aviva Plc (ADR) (NYSE:AV)

Bubbly activity in developing geographies can create large opportunities for many London-listed firms. Today, I am looking at Aviva Plc (ADR) (NYSE:AV) and assessing whether its operations in these regions are likely to underpin solid earnings growth.

Operating profit slides across the board
Aviva Plc (ADR) (NYSE:AV) reported in March that operating profit declined 15% in 2012 to 2.1 billion pounds, with weakness reported across the entire group. In life insurance and the general insurance and health division, profit dropped 5% and 4%, respectively. Fund management profit fell 16% to 51 million pounds.

The company is still highly geared toward European markets. About 48% of 2012′s operating profit from its life insurance business was generated from its operations in the U.K. and Ireland. Domestic activities also accounted for 55% of profit within general insurance and health.

Although the company has exposure to lucrative emerging markets, these areas account for less than 13% of total group operating profit, and they performed badly in 2012. Life insurance operating profit from its Poland division fell 8% to 153 million pounds, while in Asia profit collapsed 36% to 69 million pounds. Profit from other higher-growth geographies doubled to 8 million pounds, but this is measly in relation to group totals.

The drop in profits from developing markets came despite life insurance operating profit from Singapore rising 25% last year to 65 million pounds. In Eastern Europe, for example, the impact of a difficult economic backdrop and regulatory changes affected product sales. Elsewhere, operating losses from life and general insurance businesses in Turkey extended to 22 million pounds from 9 million pounds the previous year; regulatory changes affected revenues from India; and high interest rates in China whacked the popularity of its savings products there.

In my opinion, enduring difficulties in Aviva Plc (ADR) (NYSE:AV)’s key Western European markets, as well as a lack of respite due to its already-small exposure to developing regions, is likely to keep Aviva Plc (ADR) (NYSE:AV) under the cosh.

So is Aviva a buy?
City analysts expect earnings per share to keep edging lower in the near term — this is anticipated to fall to 43 pence in 2013 from 45 pence last year before rebounding modestly to 46 pence in 2014.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!